The purpose of this study is to describe and quantify the difference in societal costs incorporated in economic evaluations and cost-of-illness studies on alcohol abuse.
In the past decade, however, there has been a growing body of evidence supporting a more central role for medications in the treatment of alcohol dependence. Cost to the patient will be higher, depending on prescription filling fee Naltrexone is an opioidreceptor antagonist approved for use in the treatment of alcohol dependence in conjunction with psychosocial interventions.
These medications, the evidence supporting them, and recommended dosages are discussed in the following. Cost to the patient will be higher, depending on prescription filling fee Estimated cost to the pharmacist based on average wholesale prices (rounded to the nearest dollar) in Red Book. It is believed that naltrexone works through its blockage of μopioid receptors, which reduces the reinforcing effects of alcohol leading to decreased feelings of intoxication and fewer cravings.
Alcohol abuse results in problems on various levels in society.
In terms of health, alcohol abuse is not only an important risk factor for chronic disease, but it is also related to injuries.
For information about the SORT evidence rating system, see page 1639 or = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series.